Our pets can suffer from arthritis, just like their human owners. For years, the only treatment has been non-steroidal anti-inflammatory drugs (NSAIDS.) However, two drugs have recently been approved by the FDA for our pets.
Here are links to information we talked about today:
- Listen to Dr. Tamara Grubb’s first visit to The Family Pet Podcast in Episode 35
- This explainer from the Cleveland Clinic explains monoclonal antibodies in human medicine and is a good insight into what the future might hold for pet medicine
- Dog owners can learn about Librela
- Cat owners can learn about Solensia
Zoetis announced the U.S. commercial launch of Librela (bedinvetmab injection), which the company says is the first and only anti-NGF monoclonal antibody treatment to control canine osteoarthritis pain. The product in May received approval from the FDA.
Got a question for Michael and Stephen? Run across something interesting you want to share with the show? Do you have a topic idea for a future episode? Send it to us at thefamilypetpodcast@gmail.com.
